Bupivacaine Liposome

68 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

440.0%

Death Rate

Active Ingredients

Bupivacaine Liposome

Administration Routes

UnknownParenteralSubcutaneousOtherIntravenousIntraocularTopical

Species Affected

Unknown 35

Dog 31

Cat 1

Human 1

Most Affected Breeds

Unknown 36

Dog (unknown) 6

Retriever - Labrador 3

Siberian Husky 3

Shiba Inu 2

Shih Tzu 2

Spaniel - Cocker American 1

Collie - Border 1

Cat (other) 1

Havanese 1

Most Reported Reactions

Suspension, Abnormal 14

Incorrect storage of drug 13

Vials, Damaged 7

Vials, Leaking 6

Closure, Abnormal 5

Lethargy (see also Central nervous system depression in Neurological) 5

Shaking 4

Containers, Damaged 4

Injection site bruising 4

Lack of efficacy - NOS 3

Behavioural disorder NOS 3

Not eating 3

Outcome Breakdown

Recovered/Normal

19 (57.6%)

Outcome Unknown

6 (18.2%)

Ongoing

5 (15.2%)

Died

2 (6.1%)

Euthanized

1 (3.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.